Anebulo PharmaceuticalsANEB
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 18 institutions reported holding Anebulo Pharmaceuticals Inc. (ANEB) in their 13F filings, unchanged from Q1 2025. 2 opened new positions and 2 sold out. The largest holders were 22NW, LP ($22.3M), Nantahala Capital Management, LLC ($4.4M) and Mangrove Partners Im, LLC ($3.6M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Anebulo Pharmaceuticals Inc.
- CUSIP
- 034569103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2K |
| Exits | 2 | $30K |
All 13F filers, Q1 2025 → Q2 2025: 38,672 shares bought and 64,968 shares sold, net −26,296 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| 22NW, LP | 14.03% | No change | 15,467,300 | $22.3M |
| Nantahala Capital Management, LLC | 0.31% | No change | 3,036,325 | $4.4M |
| Mangrove Partners Im, LLC | 0.40% | No change | 2,525,252 | $3.6M |
| Morgan Stanley | 0.00% | No change | 399,219 | $575K |
| LVW Advisors, LLC | 0.06% | No change | 349,617 | $503K |
| Vanguard Group Inc. | 0.00% | Add +5.6% | 215,951 | $311K |
| Geode Capital Management, LLC | 0.00% | Add +0.1% | 205,720 | $296K |
| Ikarian Capital, LLC | 0.08% | No change | 157,720 | $227K |
| Millennium Management | 0.00% | Reduce -3.2% | 153,809 | $221K |
| Citadel Advisors | 0.00% | Add +124.0% | 25,017 | $36K |
| Boothbay Fund Management, LLC | 0.00% | No change | 18,836 | $27K |
| BlackRock, Inc. | 0.00% | Add +198.7% | 17,213 | $25K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -75.8% | 11,600 | $17K |
| Bank of America Corp. | 0.00% | Add +1.1% | 3,485 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -8.1% | 3,252 | $5K |
| PNC Financial Services Group, Inc. | 0.00% | New | 1,528 | $2K |
| UBS Group AG | 0.00% | Add +9100.0% | 92 | $132 |
| Ameritas Advisory Services, LLC | 0.00% | New | 10 | $14 |
"% of holder's portfolio" is ANEB's weight in each manager's 13F, not the share of Anebulo Pharmaceuticals Inc. the manager owns.